| 1 |
33788346 | VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer. | 2021 May |
1 |
| 2 |
30197755 | "Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signaling. | 2018 Aug 21 |
1 |
| 3 |
27274273 | Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors. | 2016 |
1 |
| 4 |
25390346 | Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats. | 2014 |
1 |
| 5 |
23457647 | The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. | 2013 |
1 |
| 6 |
19111676 | Functions of epidermal growth factor receptor in cisplatin response of thyroid cells. | 2009 Mar 15 |
8 |
| 7 |
15833856 | Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model. | 2005 Apr 15 |
4 |